To perform batch release testing and to conduct stability studies of Ribavirin, Ritonavir and Lopinavir in pharmaceutical solid products, a stability-indicating analytical method is required to separate the active pharmaceutical ingredient peak from the peaks of all potential degradation products, process related impurities, potential packaging leachable, excipients,